Patents by Inventor April C. Carpenter

April C. Carpenter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transplantation therapies
    Patent number: 10723744
    Abstract: Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: July 28, 2020
    Inventors: Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
  • Transplantation Therapies
    Publication number: 20200199145
    Abstract: Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 25, 2020
    Inventors: Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
  • Transplantation Therapies
    Publication number: 20200199146
    Abstract: Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 25, 2020
    Inventors: Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
  • TRANSPLANTATION THERAPIES
    Publication number: 20180291033
    Abstract: Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 8, 2018
    Publication date: October 11, 2018
    Inventors: Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
  • Transplantation therapies
    Patent number: 9994585
    Abstract: Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: June 12, 2018
    Assignee: Aphios Corporation
    Inventors: Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
  • TRANSPLANTATION THERAPIES
    Publication number: 20150094363
    Abstract: Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 30, 2014
    Publication date: April 2, 2015
    Inventors: Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
  • CHRONIC INFLAMMATION AND TRANSPLANTATION
    Publication number: 20120309818
    Abstract: Embodiments of the present invention feature methods for treating inflammatory disease and transplantation characterized in that it includes: (i) the incubation of organs with one or more Bryostatin-1 derivatives under conditions which permits vascular exposure to these compounds prior to or immediately following organ ‘harvesting’, and (ii) intravenous, transdermal, intraperitoneal, intra-alveolar instillation of Bryostatin-1 in vivo during active disease, or during periods of disease remission and (iii) prophylactic administration of Bryostatin-1 to limit the development of GVHD.
    Type: Application
    Filed: January 20, 2012
    Publication date: December 6, 2012
    Inventors: Jonathan Steven ALEXANDER, April C. Carpenter, Trevor Percival Castor